Today, the highest representatives of the universities and research centres of Catalonia (60 institutions, representing around 90% of the university and research community) have met to assess the c
Latest news
-
Official statement from the Universities and Research Centres of Catalonia -
BIST and UPF launch the first Master of Multidisciplinary Research in Experimental Sciences -
Internal mechanism found to be responsible for the limitless growth potential of epithelial tumours -
Europe gives a boost to Supek’s research in cancer genomics
News
12 Sep 2017
The Master Multidisciplinary Research in Experimental Sciences, a joint academic programme between the Department of Experimental
6 Sep 2017
Today, the European Research Council (ERC) has announced the award of its Starting Grants to 406 early-career researchers throughout Europe.
Media mentions
19 Sep 2017
Oscar Flores: “We don’t want a company to just hobble along: we’ll make our mark or die trying”
Biocat News
Biocat news channel interviews Oscar Flores, co-founder and CEO of Made of Genes. An IRB Barcelona alumnus, Oscar did his PhD in Biomedicine at IRB Barcelona and the Barcelona Supercomputing Center (BSC).
17 Sep 2017
Levante
A study done by IRB Barcelona inspires a school in Castellón to carry out a project on food that has been selected as a finalist in an international initiative called "I CAN School Challenge". This news is reported by the newspaper Levante, El Mercantil Valenciano.
15 Sep 2017
Non-Alcoholic Wine to Fight Cancer
Farmanatur
Farmanatur has echoed that Sin Alcohol S.L. and the Spanish Association against Cancer (abbreviated to AECC in Spanish) have agreed to launch two exclusive dealcoholized wines. For each bottle of WIN.O White or Red sold, 0.60 € will be devoted to a study financed by the AECC. Dr.
Laura Boulan
PhD Student
«I discovered that the bantam molecule drives the transition from larva to pupa, the phase analogous to human adolescence.»
More info about this news here.
Laura Nevola
Research Associate
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Meritxell Teixidó
Research Associate
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
Felice Alessio Bava
former PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
Jalaj Gupta
Postdoctoral Fellow
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Lara Barrio
Postdoctoral Fellow
“From our study in Drosophila flies we can deduce that it would be particularly interesting to address vertebrates and analyse the participation of p53 in diabetes and obesity”
More on this news here
Eduard Batlle
Group Leader
Group: Colorectal cancer laboratory
«We need to look at the soil, not at the seed. TGF-beta is the fertiliser that changes the earth in which the tumour seed grows.»
More info about this news here.
Photo gallery
Ageing is exacerbated by alterations of stem cell circadian rhythm
Ageing is exacerbated by alterations of stem cell circadian rhythm
Researchers identify the component that allows a lethal type of bacteria to spread resistance to antibiotics
Researchers at IRB Barcelona discover a crucial gene involved in the development of the placenta
Researchers at IRB Barcelona discover a crucial gene involved in the development of the placenta
Excess muscle glycogen in mice impairs endurance exercise performance
Excess muscle glycogen in mice impairs endurance exercise performance
A small group of neurons modulates the amount of insulin that the pancreas must produce
The loss of protein Dnmt3a increases the number of carcinogen-induced squamous tumours
A genome-editing strategy to study cancer stem cells in human tumours
Contact
Quick facts about IRB
Quick facts
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.
Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.